Neurologic Disorders Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Publish Date : 2021-03-14 | Publisher : 99Strategy | No Of Page : 94 | Report Id : MRB000118846 |

   

Report

MRB

Neurologic Disorders Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Publish Date: 2021-03-14 No Of Page: 94 Report Id: MRB000118846 Publisher: 99Strategy Category: Medical Care

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Neurologic Disorders Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Neurologic Disorders Therapeutics market segmented into
Central Nervous System (CNS)
Peripheral Nervous System (PNS)

Based on the end-use, the global Neurologic Disorders Therapeutics market classified into
Paralysis
Muscle Weakness
Poor Coordination
Loss of Sensation
Seizures
Confusion
Pain and Altered Levels of Consciousness

Based on geography, the global Neurologic Disorders Therapeutics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Biogen Inc.
F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services Inc.
Novartis AG
Pfizer Inc.

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NEUROLOGIC DISORDERS THERAPEUTICS INDUSTRY
2.1 Summary about Neurologic Disorders Therapeutics Industry
2.2 Neurologic Disorders Therapeutics Market Trends
2.2.1 Neurologic Disorders Therapeutics Production & Consumption Trends
2.2.2 Neurologic Disorders Therapeutics Demand Structure Trends
2.3 Neurologic Disorders Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Central Nervous System (CNS)
4.2.2 Peripheral Nervous System (PNS)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Paralysis
4.3.2 Muscle Weakness
4.3.3 Poor Coordination
4.3.4 Loss of Sensation
4.3.5 Seizures
4.3.6 Confusion
4.3.7 Pain and Altered Levels of Consciousness
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Central Nervous System (CNS)
5.2.2 Peripheral Nervous System (PNS)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Paralysis
5.3.2 Muscle Weakness
5.3.3 Poor Coordination
5.3.4 Loss of Sensation
5.3.5 Seizures
5.3.6 Confusion
5.3.7 Pain and Altered Levels of Consciousness
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Central Nervous System (CNS)
6.2.2 Peripheral Nervous System (PNS)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Paralysis
6.3.2 Muscle Weakness
6.3.3 Poor Coordination
6.3.4 Loss of Sensation
6.3.5 Seizures
6.3.6 Confusion
6.3.7 Pain and Altered Levels of Consciousness
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Central Nervous System (CNS)
7.2.2 Peripheral Nervous System (PNS)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Paralysis
7.3.2 Muscle Weakness
7.3.3 Poor Coordination
7.3.4 Loss of Sensation
7.3.5 Seizures
7.3.6 Confusion
7.3.7 Pain and Altered Levels of Consciousness
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Central Nervous System (CNS)
8.2.2 Peripheral Nervous System (PNS)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Paralysis
8.3.2 Muscle Weakness
8.3.3 Poor Coordination
8.3.4 Loss of Sensation
8.3.5 Seizures
8.3.6 Confusion
8.3.7 Pain and Altered Levels of Consciousness
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Central Nervous System (CNS)
9.2.2 Peripheral Nervous System (PNS)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Paralysis
9.3.2 Muscle Weakness
9.3.3 Poor Coordination
9.3.4 Loss of Sensation
9.3.5 Seizures
9.3.6 Confusion
9.3.7 Pain and Altered Levels of Consciousness
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Biogen Inc.
10.1.2 F. Hoffmann-La Roche Ltd.
10.1.3 Johnson & Johnson Services Inc.
10.1.4 Novartis AG
10.1.5 Pfizer Inc.
10.2 Neurologic Disorders Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 Biogen Inc.
10.2.2 F. Hoffmann-La Roche Ltd.
10.2.3 Johnson & Johnson Services Inc.
10.2.4 Novartis AG
10.2.5 Pfizer Inc.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
1.Table Neurologic Disorders Therapeutics Product Type Overview
2.Table Neurologic Disorders Therapeutics Product Type Market Share List
3.Table Neurologic Disorders Therapeutics Product Type of Major Players
4.Table Brief Introduction of Biogen Inc.
5.Table Brief Introduction of F. Hoffmann-La Roche Ltd.
6.Table Brief Introduction of Johnson & Johnson Services Inc.
7.Table Brief Introduction of Novartis AG
8.Table Brief Introduction of Pfizer Inc.
9.Table Products & Services of Biogen Inc.
10.Table Products & Services of F. Hoffmann-La Roche Ltd.
11.Table Products & Services of Johnson & Johnson Services Inc.
12.Table Products & Services of Novartis AG
13.Table Products & Services of Pfizer Inc.
14.Table Market Distribution of Major Players
15.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
16.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
17.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
18.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
19.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
20.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f

Ophthalmology Disorders Drug Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segme ...
Published Date :  2021-03-14

Thyroid Gland Disorders Treatment Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segme ...
Published Date :  2021-03-14

Substance Use Disorders (SUDs) Treatment Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segme ...
Published Date :  2021-03-14

2015-2025 Global Substance Use Disorders (SUDs) Treatment Market Research by Type, End-Use and Region

Summary The global Substance Use Disorders (SUDs) Treatment market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market D ...
Published Date :  2020-10-20

2015-2025 Global Ophthalmology Disorders Drug Market Research by Type, End-Use and Region (COVID-19 Version)

Summary The global Ophthalmology Disorders Drug market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition an ...
Published Date :  2020-10-20